How much does the targeted drug neratinib (neratinib) cost?

Neratinib (Neratinib) is an oral, small molecule targeted drug commonly used to treat breast cancer. It belongs to a class of tyrosine kinase inhibitors and works mainly by inhibiting the activity of HER2 (human epidermal growth factor receptor 2).

Neratinib (neratinib) has now been launched in the domestic market and has been successfully included in the medical insurance system. Patients can purchase it in the country, and the price is approximately between seven and eight thousand yuan. Regarding specific drug pricing and detailed policies on medical insurance reimbursement, it is recommended that you consult the pharmacy of your local hospital to obtain the most accurate information. In addition, if you are looking for a more economical option, the price of Bangladeshi generic neratinib is relatively affordable, about more than 3,000 yuan, which is nearly half the price compared to the domestic market, and its drug ingredients are basically the same as the domestic version, making it a cost-effective option.

Breast cancer is a common malignant tumor in which approximately 20% to 25% of patients have tumors that express high levels of HER2 protein. HER2 is a cell surface receptor involved in regulating cell growth and differentiation. When abnormally activated, it can lead to abnormal growth and spread of tumors. Therefore, HER2 is regarded as an important target in breast cancer treatment.

Neratinib blocks the signaling pathways of cancer cells by inhibiting the activity of HER2 receptors, thereby inhibiting the growth and spread of tumors. Compared with some other targeted therapies, neratinib (neratinib) is characterized by its long-lasting effect, which can continue to inhibit HER2 signaling after stopping taking it, which is called "post-treatment effect".

Neratinib is usually used to treat patients with HER2-positive advanced or metastatic breast cancer who have received other treatments. It is often used as a single agent or in combination with other treatments, such as chemotherapy drugs.